Source:http://linkedlifedata.com/resource/pubmed/id/15719154
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
11
|
| pubmed:dateCreated |
2005-10-24
|
| pubmed:abstractText |
Given the implications with respect to the pathogenesis of dopaminergic dysfunction in schizophrenia and Parkinson's disease (PD), as well as the reciprocal antagonistic interactions between adenosine A2a receptor (A2aAR) and the dopamine D2 receptors, A2aAR may be a candidate gene conferring susceptibility to PD or schizophrenia. In this study, we tested the hypothesis that the A2aAR 1976T > C genetic variant confers susceptibility to or is related to the onset age of schizophrenia or PD using a sample population consisting of 94 PD and 227 schizophrenic patients. We also tested whether the A2aAR 1976T > C relates to antipsychotic-induced tardive dyskinesia in the schizophrenic population. The results demonstrated that in comparing PD patients and controls the distribution of the A2aAR 1976T > C genotypes (P=0.788) and alleles (P=0.702) did not vary significantly. Furthermore, the PD onset age was not significantly different amongst the three A2aAR 1976T > C genotypic groups. In comparing schizophrenic patients and controls, the distribution of the A2aAR genotypes (P=0.330) and alleles (P=0.632) also did not differ significantly. The onset age of schizophrenia and tardive dyskinesia (evaluated with Abnormal Involuntary Movements Scale) were similar within the three A2aAR genotypic groups. Our findings suggest that it is unlikely that the A2aAR 1976T > C polymorphism plays a major role in the pathogenesis of PD, schizophrenia, or antipsychotic-induced tardive dyskinesia in the Chinese population.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Nov
|
| pubmed:issn |
0300-9564
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
112
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1503-10
|
| pubmed:dateRevised |
2009-11-19
|
| pubmed:meshHeading |
pubmed-meshheading:15719154-Age Distribution,
pubmed-meshheading:15719154-Age of Onset,
pubmed-meshheading:15719154-Aged,
pubmed-meshheading:15719154-Asian Continental Ancestry Group,
pubmed-meshheading:15719154-Base Sequence,
pubmed-meshheading:15719154-Brain,
pubmed-meshheading:15719154-Brain Chemistry,
pubmed-meshheading:15719154-Cytosine,
pubmed-meshheading:15719154-DNA Mutational Analysis,
pubmed-meshheading:15719154-Dyskinesia, Drug-Induced,
pubmed-meshheading:15719154-Female,
pubmed-meshheading:15719154-Genetic Predisposition to Disease,
pubmed-meshheading:15719154-Genetic Testing,
pubmed-meshheading:15719154-Genotype,
pubmed-meshheading:15719154-Humans,
pubmed-meshheading:15719154-Male,
pubmed-meshheading:15719154-Middle Aged,
pubmed-meshheading:15719154-Parkinson Disease,
pubmed-meshheading:15719154-Point Mutation,
pubmed-meshheading:15719154-Polymorphism, Genetic,
pubmed-meshheading:15719154-Receptor, Adenosine A2A,
pubmed-meshheading:15719154-Schizophrenia,
pubmed-meshheading:15719154-Sex Distribution,
pubmed-meshheading:15719154-Taiwan,
pubmed-meshheading:15719154-Thymine
|
| pubmed:year |
2005
|
| pubmed:articleTitle |
Association studies of the adenosine A2a receptor (1976T > C) genetic polymorphism in Parkinson's disease and schizophrenia.
|
| pubmed:affiliation |
Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|